On Friday, Texas Instruments Incorporated (NASDAQ:TXN)’s shares inclined 0.34% to $47.57.
Texas Instruments Incorporated (TXN) Vice President Dave Pahl will speak at the 2015 Deutsche Bank Technology Conference in Las Vegas on Thursday, September 17, at 2:40 p.m. Pacific time. Pahl will field questions from analysts and investors, in addition to talk about TI’s business outlook and its strategy to address key markets for its analog and embedded processing technologies and how these capabilities position the company for growth.
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing. The Analog segment offers high volume analog and logic products for automotive safety devices, touch screen controllers, low voltage motor drivers, and integrated motor controllers; and power administration products to enhance the efficiency of powered devices using battery administration solutions, portable power conversion devices, power supply controls, and point-of-load products.
Comcast Corporation (NASDAQ:CMCSA)’s shares dropped -0.23% to $56.41.
Comcast Business declared that Hilton San Francisco Union Square hotel has upgraded its Comcast Business Ethernet services spanning its 1919 guest rooms and 130,000 square feet of meeting space, to provide a strong and reliable Internet experience for its guests. With the upgrade, Hilton San Francisco Union Square has moved from two Internet circuits of 500Mbps to two dedicated 1Gbps circuits, upgradable to 10Gbps.
Hilton San Francisco Union Square, the brand’s largest property in the Western U.S. and the largest hotel in San Francisco, hosts a variety of corporate clients counting leading organizations in the tech sector, making it imperative that its Internet offering is high-speed, reliable, flexible to scale and able to rapidly respond to the demands of its clientele in both its guest rooms and meeting spaces. It is equally important for the hotel to be able to provide the bandwidth to support guests’ social activities counting streaming video or other content to keep in touch with loved ones, while meeting industry standards to support up to 6,000 guests online at the same time.
Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Netoperates, Broadcast Television, Filmed Entertainment, and Theme Parks segments. The Cable Communications segment offers video, high-speed Internet, and voice services to residential and business customers under the XFINITY brand name. This segment also provides business services, such as cellular backhaul services to mobile network operators; Ethernet network services; and online advertising services.
At the end of Friday’s trade, Gilead Sciences, Inc. (NASDAQ:GILD)‘s shares surged 2.22% to $109.63.
Gilead Sciences, Inc. (GILD) declared the pricing of senior unsecured notes in an aggregate principal amount of $10 billion, in an underwritten, registered public offering, compriseing of six tranches:
- $1,000 million of 1.850% senior notes maturing in 2018
- $2,000 million of 2.550% senior notes maturing in 2020
- $1,000 million of 3.250% senior notes maturing in 2022
- $2,750 million of 3.650% senior notes maturing in 2026
- $1,000 million of 4.600% senior notes maturing in 2035
- $2,250 million of 4.750% senior notes maturing in 2046
The senior notes are rated A- by Standard & Poor’s and A3 by Moody’s. The offering is predictable to close September 14, 2015, subject to customary closing conditions.
Gilead intends to use the net proceeds from the offering for general corporate purposes, which may comprise the repayment of debt, working capital, payment of dividends and the repurchase of its outstanding common stock following its authorized share repurchase program.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. The company’s products comprise Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver disease.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
